Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Española de Enfermedades Digestivas
versión impresa ISSN 1130-0108
Resumen
CABEZAS, Joaquín et al. Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy. Rev. esp. enferm. dig. [online]. 2016, vol.108, n.7, pp.421-430. ISSN 1130-0108. https://dx.doi.org/10.17235/reed.2015.3894/2015.
Hepatitis C therapy in the era of the newer direct-acting antiviral agents has radically changed our treatment schemes by achieving very high rates of sustained virological response. However, treatment with direct antiviral agents fails in a subgroup of patients. This group of so-called difficult-to-treat individuals is the subject of this paper, which reviews the causes of virological failure, their clinical implications, and some final recommendations.
Palabras clave : Hepatitis C; Direct-acting antiviral therapy; Resistance-associated variants; Treatment failure.